These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2551399)

  • 1. Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent.
    DeMet EM; Gerner RH; Bell KM; Kauffmann CD; Chicz-DeMet A; Warren S
    Biol Psychiatry; 1989 Sep; 26(5):478-88. PubMed ID: 2551399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
    Hrdina PD; Lapierre YD; Horn ER; Bakish D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic imipramine treatment on subclasses of platelet 3H-imipramine binding sites and plasma cortisol.
    DeMet EM; Chicz-DeMet A; Bell KM; Reist C; Gerner RH
    Psychiatry Res; 1990 Dec; 34(3):303-13. PubMed ID: 1963693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-imipramine binding to freshly prepared platelet membranes in depression.
    Theodorou AE; Katona CL; Davies SL; Hale AS; Kerry SM; Horton RW; Kelly JS; Paykel ES
    Psychiatry Res; 1989 Jul; 29(1):87-103. PubMed ID: 2549556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.
    Takeda T; Harada T; Otsuki S
    Biol Psychiatry; 1989 May; 26(1):52-60. PubMed ID: 2541808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
    Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
    J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet [3H]-imipramine binding according to DSM-III subtypes of depression.
    Jeanningros R; Gronier B; Azorin JM; Tissot R
    Neuropsychobiology; 1989; 22(1):33-40. PubMed ID: 2561683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression.
    Langer SZ; Sechter D; Loo H; Raisman R; Zarifian E
    Arch Gen Psychiatry; 1986 Oct; 43(10):949-52. PubMed ID: 3019267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet 3H-imipramine binding: a state-dependent marker in depression.
    Suranyi-Cadotte B; Quirion R; McQuade P; Nair NP; Schwartz G; Mosticyan S; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):737-41. PubMed ID: 6531445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet imipramine binding in endogenous depressed patients and controls: relationship to platelet MAO and 5HT uptake during successful imipramine treatment.
    Quintana J
    Psychiatry Res; 1990 Sep; 33(3):229-42. PubMed ID: 2173840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorder.
    Wägner A; Aberg-Wistedt A; Asberg M; Bertilsson L; Mårtensson B; Montero D
    Arch Gen Psychiatry; 1987 Oct; 44(10):870-7. PubMed ID: 2821953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet imipramine binding in depressed children and adolescents.
    Ambrosini PJ; Metz C; Arora RC; Lee JC; Kregel L; Meltzer HY
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):298-305. PubMed ID: 1314256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine binding in depressive patients diagnosed according to different criteria.
    Plenge P; Mellerup ET; Gjerris A
    Acta Psychiatr Scand; 1988 Aug; 78(2):156-61. PubMed ID: 2851919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet tritiated imipramine binding in psychiatric patients: relationship to symptoms and severity of depression.
    Ellis PM; McIntosh CJ; Beeston R; Salmond CE; Cooke RR; Mellsop G
    Acta Psychiatr Scand; 1990 Oct; 82(4):275-82. PubMed ID: 2175538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity 3H-imipramine binding sites: a possible state-dependent marker for major depression.
    Marazziti D; Perugi G; Deltito J; Lenzi A; Maremmani I; Placidi GF; Cassano GB
    Psychiatry Res; 1988 Feb; 23(2):229-37. PubMed ID: 2834766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological markers in juvenile depression.
    Carstens ME; Engelbrecht AH; Russell VA; van Zyl AM; Taljaard JJ
    Psychiatry Res; 1988 Jan; 23(1):77-88. PubMed ID: 2834765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phototherapy on 3H-imipramine binding sites in patients with SAD, non-SAD and in healthy controls.
    Szádóczky E; Falus A; Németh A; Teszéri G; Moussong-Kovács E
    J Affect Disord; 1991 Aug; 22(4):179-84. PubMed ID: 1658102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.